tiprankstipranks
Trending News
More News >
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5d ago
Alumis Inc. Reports Q1 2025 Financial Results and Strategic Progress
Premium
Company Announcements
Alumis Inc. Reports Q1 2025 Financial Results and Strategic Progress
5d ago
Alumis price target lowered to $25 from $26 at Oppenheimer
Premium
The Fly
Alumis price target lowered to $25 from $26 at Oppenheimer
6d ago
Acelyrin urges stockholders to vote for proposed merger with Alumis
PremiumThe FlyAcelyrin urges stockholders to vote for proposed merger with Alumis
20d ago
Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition
Premium
Ratings
Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition
21d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
23d ago
Strategic Partnerships and Financial Projections Bolster Buy Rating for Alumis Inc.
PremiumRatingsStrategic Partnerships and Financial Projections Bolster Buy Rating for Alumis Inc.
2M ago
Alumis, Kaken Pharmaceutical enter ESK-001 collaboration and licensing agreement
Premium
The Fly
Alumis, Kaken Pharmaceutical enter ESK-001 collaboration and licensing agreement
2M ago
Positive Buy Rating for Alumis Inc. Driven by Promising TYK2 Inhibitors and Strategic Advancements
Premium
Ratings
Positive Buy Rating for Alumis Inc. Driven by Promising TYK2 Inhibitors and Strategic Advancements
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100